Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Richmond, VA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Chippenham Medical Center
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
248
mi
from 43215
Roanoke, VA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Carilion Roanoke Memorial Hospital
248
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
393
mi
from 43215
Madison, WI
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Meriter Hospital, Inc.
393
mi
from 43215
Madison, WI
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
702
mi
from 43215
Mobile, AL
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Springhill Medical Center
702
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
412
mi
from 43215
Rome, GA
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Redmond Regional Medical Center
412
mi
from 43215
Rome, GA
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
163
mi
from 43215
Carmel, IN
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
IU Health North Medical Center
163
mi
from 43215
Carmel, IN
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
166
mi
from 43215
Indianapolis, IN
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Community Heart and Vascular Hospital
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
233
mi
from 43215
Saint Joseph, MI
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Lakeland Hospitals at St. Joseph
233
mi
from 43215
Saint Joseph, MI
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
617
mi
from 43215
Saint Paul, MN
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
United Hospital - St. Paul Heart Clinic
617
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
477
mi
from 43215
New York, NY
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
349
mi
from 43215
Charlotte, NC
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Novant Health Presbyterian Medical Center
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
914
mi
from 43215
Dallas, TX
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
VA North Texas Health Care System
914
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
1511
mi
from 43215
Salt Lake City, UT
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
University of Utah Hospital and Clinics
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  12/31/1969
476
mi
from 43215
Weston, WI
PROMUS Element Plus US Post-Approval Study
A U.S. Post-Approval Study of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 12/31/1969
Marshfiled Clinic
476
mi
from 43215
Weston, WI
Click here to add this to my saved trials
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated:  12/31/1969
412
mi
from 43215
Suwanee, GA
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated: 12/31/1969
John's Creek Primary Care
412
mi
from 43215
Suwanee, GA
Click here to add this to my saved trials
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated:  12/31/1969
802
mi
from 43215
Baton Rouge, LA
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated: 12/31/1969
The Lipid Center
802
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated:  12/31/1969
348
mi
from 43215
Charlotte, NC
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated: 12/31/1969
Carolina Family Healthcare
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated:  12/31/1969
849
mi
from 43215
Bonham, TX
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
Investigation of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Primary Care Practice Pattern
Status: Enrolling
Updated: 12/31/1969
Family Care Clinic
849
mi
from 43215
Bonham, TX
Click here to add this to my saved trials
Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
Phase 3 Trial of Intravenous Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
Status: Enrolling
Updated:  12/31/1969
480
mi
from 43215
New York, NY
Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
Phase 3 Trial of Intravenous Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients
The Effect of Selective Pulmonary Vasodilation on Ventricular Afterload and Ventricular-arterial Coupling in Patients With Fontan Physiology and Validation of Echocardiographic Measures of Systolic and Diastolic Function.
Status: Enrolling
Updated:  12/31/1969
2109
mi
from 43215
San Francisco, CA
Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients
The Effect of Selective Pulmonary Vasodilation on Ventricular Afterload and Ventricular-arterial Coupling in Patients With Fontan Physiology and Validation of Echocardiographic Measures of Systolic and Diastolic Function.
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
328
mi
from 43215
Washington,
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Washington DC VA Medical Center, Washington, DC
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
716
mi
from 43215
Gainesville, FL
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
716
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
662
mi
from 43215
Jackson, MS
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
662
mi
from 43215
Jackson, MS
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
1333
mi
from 43215
Albuquerque, NM
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
477
mi
from 43215
New York, NY
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
351
mi
from 43215
Durham, NC
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Durham VA Medical Center, Durham, NC
351
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
97
mi
from 43215
Cincinnati, OH
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
129
mi
from 43215
Cleveland, OH
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
849
mi
from 43215
Oklahoma City, OK
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Oklahoma City VA Medical Center, Oklahoma City, OK
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
995
mi
from 43215
Houston, TX
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
243
mi
from 43215
Salem, VA
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Salem VA Medical Center, Salem, VA
243
mi
from 43215
Salem, VA
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
433
mi
from 43215
Decatur, GA
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
459
mi
from 43215
Iowa City, IA
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Iowa City VA Health Care System, Iowa City, IA
459
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
163
mi
from 43215
Ann Arbor, MI
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
163
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated:  12/31/1969
1154
mi
from 43215
Aurora, CO
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Regional VA Medical Center, Aurora, CO
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators
Dietary Carbohydrate Type and CVD Risk Indicators
Status: Enrolling
Updated:  12/31/1969
643
mi
from 43215
Boston, MA
Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators
Dietary Carbohydrate Type and CVD Risk Indicators
Status: Enrolling
Updated: 12/31/1969
Jean Mayer Human Nutrition Research Center on Aging
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
845
mi
from 43215
Lafayette, LA
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
845
mi
from 43215
Lafayette, LA
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
850
mi
from 43215
Concord, CA
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
850
mi
from 43215
Concord, CA
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
1953
mi
from 43215
Mission Viejo, CA
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1953
mi
from 43215
Mission Viejo, CA
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
537
mi
from 43215
New Haven, CT
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
393
mi
from 43215
Gainesville, GA
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
393
mi
from 43215
Gainesville, GA
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
166
mi
from 43215
Indianapolis, IN
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
460
mi
from 43215
Iowa City, IA
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
715
mi
from 43215
Lewiston, ME
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
715
mi
from 43215
Lewiston, ME
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
327
mi
from 43215
Takoma Park, MD
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
327
mi
from 43215
Takoma Park, MD
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
618
mi
from 43215
Kansas City, MO
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
585
mi
from 43215
Springfield, MO
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
585
mi
from 43215
Springfield, MO
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
468
mi
from 43215
Newark, NJ
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
481
mi
from 43215
New York, NY
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated:  12/31/1969
481
mi
from 43215
New York, NY
BIOHELIX-I Bare Metal Stent Study
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials